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REDUCE CELL TOXICITY AND INFLAMMATION IN VIVO IN MICE 
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Biological Chemistry; Pediatrics, University of Michigan Medical Center, Ann Arbor, United 
States 
 
Introduction: Clotting Factor VIII (FVIII) secretion is limited due to protein misfolding in the 
endoplasmic reticulum (ER). Recently we demonstrated that expression of FVIII, as well as B 
domain deleted (BDD) FVIII, in the livers of mice activates the Unfolded Protein Response (UPR), 
an inflammatory response, oxidative stress, and apoptosis. In contrast, a more efficiently secreted 
form of FVIII, 226/N6 (MIao et al.), did not induce any of these responses. In this study we 
evaluated the effect of anti-oxidant treatment on these toxic responses and FVIII secretion in mice. 
Methods: FVIII was expressed in liver by DNA injection of FVIII expression vectors into the tail 
veins of mice. The anti-oxidant butylated hydroxyanisole (BHA) was added to mouse chow 4 days 
prior to DNA injection. Cellular responses and and FVIII secretion were studied at 48 hr after DNA 
injection. 
Results: Feeding mice with BHA prevented UPR activation, apoptosis, oxidative stress, and the 
inflammatory response associated with FVIII and BDD FVIII expression. Surprisingly, BHA feeding 
also increased secretion of FVIII and BDD factor VIII into the plasma approximatley 3-4 fold, where 
it had no effect on secretion of 226/N6 FVIII. Finally, BHA feeding increased by 6-fold the secretion 
of a folding-defective functional FVIII mutant Arg593-Cys that is known to cause hemophilia A. 
Conclusions: Anti-oxidant treatment prevents oxidative stress and activation of the inflammatory 
response, the UPR, and apoptosis, and and also increases FVIII secretion. The results implicate the 
significance of oxidative stress on ER function. Anti-oxidants may be a useful adjuvant to improve 
FVIII secretion of in gene therapy, as well as improve secretion of folding-defective mutant FVIII 
molecules in patients with hemophilia A. 
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